Presentations from the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

 

 

SESSION I: PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER: SCREENING AND CLINICAL
EVALUATION OF MEN WITH CLINICAL SUSPICION

Welcome and Opening Remarks

Faina Shtern, MD, presented opening remarks for Sixth Global Summit on Precision Diagnosis and Treatment of Prostate Cancer.

Risk-Stratified Screening and Early Detection of Prostate Cancer in 2022

Andrew Vickers, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

PROBASE Trial: Baseline PSA in Young Men (Aged 45 and 50)

Peter Albers, MD, presented this lecture during the 6h Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

BARCODE1 Trial: Single-Nucleotide Polymorphisms (SNPs)

Jana McHugh, MB, BCh, BAO, presented this lecture during the 6h Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

IP1-Prostagram Screening Study: Comparing PSA, MRI and Ultrasound

Hashim Ahmed, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

ReIMAGINE Study: Feasibility of MRI-based Screening

Caroline Moore, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Perspective from European Union and European Association of Urology on Screening: PSA, Risk Calculator and MRI

Henrik Van Poppel, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Göteborg-2 Trial: PSA Screening Followed by MRI

Jonas Hugosson, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Clinical Trial of STHLM3 and MRI

Martin Eklund, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

PROSCREEN: A Randomized Population-Based Screening Trial Combining PSA, Kallikrein Panel and MRI

Auvinen, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Early Detection of Prostate: Navigating the Challenges 2022

E. David Crawford, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Serum microRNA for Diagnosis of Prostate Cancer

Shin Egawa, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Liquid Biomarkers and MRI in Prostate Cancer – Complementary?

Sanoj Punnen, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

MDx Health’s Molecular Diagnostics Solutions for Urologic Health

Ericka M. Bagi, BSN, RN, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Advanced Ultrasound of the Prostate

Ethan J. Halpern, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

OPTIMUM Trial – Current and Emerging Evidence Supporting 29MHz High- Precision, Real-Time Micro-Ultrasound

Preston Sprenkle, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

PI-RADS Standardization and Risk Assessment- Recent Advances and Future Plans

Clare Tempany, MB, BAO, BCh, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Quality Assessment of Prostate MRI: Impact on the Diagnostic Path

Jelle Barentsz, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Deep Learning Accelerated MRI of the Prostate for Increased Throughput and MRI-targeted Biopsy for Improved Prostate Tissue Sampling

Mukesh Harisinghani, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

PRIMARY Trial – The Role of Integrated Molecular and MRI Imaging Prior to Biopsy

Louise Emmett, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

How the Addition of Multiparametric MRI has Changed a Private Practice Setting in Prostate Screening

Richard G. Barr, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Update of Changes in the Early Detection of Prostate Cancer NCCN Guidelines 2022

Preston Sprenkle, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Clinical Role of MRI in Staging and Risk Assessment

Peter Choyke, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Prostate Cancer Visibility on MRI: Histopathologic and Genomic Considerations

Andrei Purysko, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

SESSION II (PART 1). CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER

The Urinary Proteome of Prostate Cancer

Paul Boutros, PhD, MBA, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Tissue-Based Genetic Cancer Profiling Overview: (Localized and Recurrent Cancer)

Matthew R. Cooperberg, MD, MPH, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Prostate: Anatomic Considerations

Thomas M. Wheeler, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Current and Future Directions in Risk Assessment: Should Gleason 6 (GG1) be Considered Cancer?

Scott Eggener, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Clinical Role of MRI in Staging and Risk Assessment

Peter Choyke, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Prostate Cancer Visibility on MRI: Histopathologic and Genomic Considerations

Andrei Purysko, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

PET/MRI for Diagnosis and Localized Prostate Cancer

Andrei H. Iagaru, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer

Hossein Jadvar, MD, PhD, MPH, MBA, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2022.

SESSION II (PART 2): CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER

Overview of Non-Invasive and Intraoperative PSMA Imaging

Wolfgang Weber, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

MRI and Biochemical Recurrence

Valeria Panebianco, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Urologic Perspective on the Current and Emerging Role of Multi-Modality Imaging and Radiogenomics

Mohummad Minhaj Siddiqui, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Precision Theranostics of Prostate Cancer with uExplorer and Illuccix

Harshad R. Kulkarni, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

NCI Clinical Trials in Prostate Cancer Imaging and Theranostics

Lalitha K. Shankar, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Integrated Diagnostics (Radiogenomics) and Active Surveillance: Patient and Monitoring

Sanoj Punnen, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Selection and Monitoring of Image-Targeted Minimally Invasive Treatment

Fiona Fennessy, MD, PhD, BCh, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Integration of Imaging and Surgical Treatment for Localized Prostate Cancer

Adam S. Feldman, MD, MPH, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Focal Treatment of Prostate Cancer: The Case for Radiotherapy

Daniel Y. Song, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

NCCN Guidelines for Treatment of Localized Prostate Cancer

Kelvin A. Moses, MD, PhD, FACS, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

SESSION III. POPULATION OF MEN WITH ADVANCED PROSTATE CANCER

Precision Oncology for Prostate Cancer

Charles J. Ryan, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

An Update on the Advanced Prostate Cancer Consensus Conference

Robert E. Reiter, MD, MBA, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Review of the New Standard in Treatment and Global Issues: Androgen Deprivation Treatment (ADT), Chemotherapy, Androgen Receptors Inhibitors, and Androgen Synthesis Inhibitors

Marc B. Garnick, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Current and Emerging Role of the Detection and Treatment of Somatic and Germline Homologous Recombination Repair (HRR) Gene Mutations in mCRPC

Daniel P. Petrylak, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Novel Treatment and its Integration with Precision Diagnostics

David M. Nanus, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

VERACITY Clinical Trial of Sabizabulin for the Treatment of Men with mCRPC who Progressed on an Androgen Receptor Targeting Agent

Mitchell Steiner, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Immunotherapy: Why do we (Mostly) Fail?

Arnulf Stenzi, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Radiation Treatment and Its Integration with Precision Diagnostics

Alan Pollack, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

PYLARIFY® (piflufolastat F 18) Injection PET/CT Imaging in Prostate Cancer Patients

Ashley Ross, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

PSMA PET Criteria for Patient Selection and Therapy Response Assessment to LuPSMA Therapy

Jeremie Calais, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

Targeted Ablation of Prostate Cancer: UTSW’s Experience with the TULSA Procedure

Kenneth Goldberg, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2022.

SESSION IV. PRECISION DIAGNOSTICS AND EMERGING ROLE OF IMAGE-TARGETED, MINIMALLY INVASIVE TREATMENT: Multimodality Diagnostics for Improved Target Definition, Patient Selection, Monitoring & Outcomes

Precision Diagnostics and Emerging Role of Image-Targeted, Minimally Invasive Treatment: Overview

Jurgen Fütterer, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Current Clinical Trails: Focal Therapy for Prostate Cancer

John F. Feller, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

MRI Standardized Reporting for Focal Therapy Planning and Follow-up

Daniel Margolis, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Micro-Ultrasound and Focal Laser Ablation

Sangeet Ghai, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

MRI Guided Focal Laser Ablation

Aytekin Oto, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

MRI Guided Partial and Whole Prostate Gland Treatment

Steven S. Raman, MD, FSAR, FSIR, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

MRI Guided Focal Laser Ablation

Aytekin Oto, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Sight and Switch off: Nerve Density Visualization for Interventions Targeting Prostate Cancer

Liang Wang, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Urologic Perspective on Clinical Utility and Outcomes: The Importance of Close Collaboration between Radiology and Urology

Geoffrey Sonn, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Improving Prostate Focal Therapy with AI-based Cancer Mapping

Alan Priester, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

PANEL ON BIOINFORMATICS, ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR A MULTI-MODALITY DATA ANALYSIS FOR PRECISION DIAGNOSIS AND TREATMENT

Connected Care and Latest Developments in Prostate Cancer Management

Ilya Gipp, MD, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Radiologic Perspective on the Emerging and Potential Role of Machine Learning

Masoom Haider, MD, FRCP(C), presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Computational Imaging Biomarkers for Prostate Cancer Diagnosis and Prognosis

Rakesh Shiradkar, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Development of New Approaches Using Artificial Intelligence for Segmentation of Dominant Index Lesion in Prostate Cancer

Amita Dave, PhD, and Harini Veeraraghavan, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

PANEL ON PRECISION CARE AND HEALTH DISPARITIES IN PROSTATE CANCER

Current State of Knowledge: Genomics and Health Disparities

Yaw Nyame, MD, MS, MBA, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Current and Emerging Approaches to Prostate Cancer Equity

Adam B Murphy, MD, MBA, MSCI, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

Abstract Competition Winners

SMA PET/CT–based Patterns of Prostate Fossa Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy

Ida Sonni, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

True Positive 18F-rhPSMA-7.3 Lesions in Patients with Prostate Cancer Recurrence with Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter, SPOTLIGHT Study

Andrei Purykso, MD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.

A Validated Prostate Cancer Probability Map To Aid In Focal Treatment Planning

Alan Priester, PhD, presented this lecture during the 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2022.